Deoxyribozymes as Inhibitors of Vascular Smooth Muscle Cell Growth

E-ISSN： 1873-4316|5|4|337-339

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.5, Iss.4, 2004-08, pp. : 337-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of angiotensin AT 1 receptor gene expression during cell growth of vascular smooth muscle cells

By Nickenig G. Sachinidis A. Ko Y. Vetter H.

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

A non-thiazolidinedione partial peroxisome proliferator-activated receptor ligand inhibits vascular smooth muscle cell growth

By Bruemmer D. Berger J.P. Liu J. Kintscher U. Wakino S. Fleck E. Moller D.E. Law R.E.

European Journal of Pharmacology, Vol. 466, Iss. 3, 2003-04 ,pp. : 225-234

Elsevier

Access to resources Recommend Favorite

Action of Elgodipine on Atherosclerosis Development, Cell Growth, and Oncogene Expression in Vascular Smooth Muscle Cells

By Del Rio M. Ruiz E. Tejerina T.

General Pharmacology, Vol. 28, Iss. 3, 1997-03 ,pp. : 463-468

Elsevier

Access to resources Recommend Favorite

Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth

By Pons Jennifer Kitlinska Joanna Jacques Danielle Perreault Claudine Nader Moni Everhart Lindsay Zhang Ying Zukowska Zofia

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 7, 2008-07 ,pp. : 438-448

NRC Research Press

Access to resources Recommend Favorite

Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction

By Filipeanu C.M. Brailoiu E. Huhurez G. Slatineanu S. Baltatu O. Branisteanu D.D.

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 29-35

Elsevier

Access to resources Recommend Favorite